If you've seen headlines claiming NAD+ doesn’t really decline with age, you’ve probably been reading studies that measure NAD+ in whole blood. But tissue NAD+ — the amount inside organs like liver, brain, and muscle — tells a very different story. That gap between what a simple blood draw shows and what’s happening inside your cells is the central tension in NAD+ research right now.
When supplement studies track blood NAD+ and miss what’s happening in tissues, the results can look inconsistent. A Nature Metabolism study across 300 participants found whole-blood NAD+ didn’t vary with age, yet brain scans in older adults show clear declines in occipital NAD+ (Bagga et al., 2020; Zhu et al., 2015). Understanding this mismatch helps make sense of why some trials report a boost while others see nothing.
What to know about blood NAD vs tissue NAD
The difference starts with the sample itself. Whole blood is dominated by red blood cells (RBCs), which make up roughly 40–45% of its volume. These cells lack nuclei and mitochondria, so their NAD+ metabolism doesn’t directly mirror what’s happening in energy-hungry tissues like liver or muscle. Research compiled by AgelessRx notes that while whole-blood NAD+ levels appear stable across age groups, brain, liver, and skin NAD+ show measurable decline. Liver NAD+ in patients over 60, for instance, sits around 70% of that in adults under 45.
It’s not that blood NAD+ is meaningless — it’s that it reflects a different biological compartment. One study found blood and muscle NAD+ levels barely correlated. So a supplement that spikes your blood NAD+ may not change what’s inside the tissue where you actually want it.
Specs, materials, and use cases
Measuring NAD+ isn’t one-size-fits-all. The gold standard is HPLC or mass spectrometry on a tissue biopsy, but that’s invasive and rarely used outside research. Commercial dried blood spot tests are convenient — Superpower’s 150+ biomarker panel captures NAD+ alongside other metabolic markers, but it’s still a whole-blood snapshot. For brain tissue, 7‑Tesla magnetic resonance spectroscopy (MRS) can quantify NAD+ non‑invasively, though it’s limited to specialized centers.
Inside cells, NAD+ concentrations differ by location — roughly 70 micromolar in the cytoplasm and 110 micromolar in the nucleus, based on cultured cell data. Use cases track this complexity: a researcher studying aging needs tissue‑specific data; someone curious about their own levels might use a blood test, but should remember its limits. RBC‑corrected protocols and longitudinal designs could sharpen future studies.
Comparison and selection guide
Choosing an NAD+ assessment depends on what question you’re really asking. Are you looking for a research‑grade tissue measurement, or a rough gauge of circulating levels?
- Whole-blood NAD+ test: Quick, minimally invasive. Can respond to supplementation and may flag major shifts. As AboutNAD explains, blood NAD+ does react to precursors like NR, but it doesn’t reliably reflect organ‑level status — the 2019 blood‑muscle correlation was essentially zero.
- Tissue biopsy (HPLC/MS): The most accurate window into liver, muscle, or skin NAD+. Impractical for routine screening. Reserves for clinical studies or when organ‑specific decline is suspected.
- Brain MRS: Non‑invasive but expensive and hard to access. Best for tracking neurodegenerative research, where occipital NAD+ drops have been replicated across studies.
If you’re monitoring a supplement’s effect, a repeat blood test may show whether you absorbed the precursor, but it won’t prove it reached your mitochondria. For that, you’d need a tissue sample — and that’s a much bigger ask.
Frequently Asked Questions
Is the claim that NAD+ decline with age is a myth true?
No. While whole‑blood NAD+ appears stable in some cohort studies, tissue‑level declines in brain, liver, and muscle are well documented. The 2026 Nature Metabolism analysis confirmed blood stability across 300 people, but earlier work using 7‑Tesla MRS consistently found lower brain NAD+ in older adults.
Can a blood test tell me my tissue NAD+ levels?
Not reliably. A 2019 study showed blood and muscle NAD+ barely correlate. Blood NAD+ is influenced by RBC count, recent food, and other short‑term factors — so a normal reading doesn’t guarantee your organs have enough NAD+ to fuel repair enzymes.
Why do some studies show blood NAD+ rising after supplementation while human trials have mixed results?
Precursors like nicotinamide riboside can quickly elevate blood NAD+, but getting that NAD+ into tissues depends on digestion, cellular transport, and individual metabolism. The source notes that oral NAD+ precursors face a multi‑step process, which may explain why tissue‑level benefits aren’t always seen even when blood levels spike.